Plunkett Research Online: Achieve Life Sciences Inc

ACHIEVE LIFE SCIENCES INC (ACHV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation. Cytisine is an established 25-day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by Soph.....



Achieve Life Sciences Inc
Ticker: ACHV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 425 686-1500
Fax: 425 686-1600
Address: 19820 North Creek Parkway
Bothell, WA 98011 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Drugs-Cancer
ContactsDescription
John BencichCFO/Chief Accounting Officer/COO/Executive VP
Cindy JacobsChief Medical Officer/Executive VP
See More
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation. Cytisine is an established 25-day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by Soph.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor: Dorsey & Whitney LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Cytisine
Tabex
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: